Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular gene therapy: angiogenesis and beyond.

Raffi Bekeredjian1, Ralph V Shohet

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

The American Journal of the Medical Sciences
|April 20, 2004
PubMed
Summary

Gene therapy for cardiovascular diseases shows promise but faces challenges. Recent clinical trials for angiogenesis in ischemia have yielded disappointing results, necessitating a re-evaluation of future strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients.

Coronary artery disease·2026
Same author

No Boundaries for TAVI? Balancing Feasibility of TAVI in Hemodialysis Patients With Prognostic Value of Comorbidities.

JACC. Asia·2026
Same author

Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial.

American heart journal·2026
Same author

Clinical and imaging phenotypes.

European heart journal supplements : journal of the European Society of Cardiology·2026
Same author

(Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.

International journal of cardiology·2026
Same author

Sustained mesenchymal reprogramming of endothelial cells after completion of chemotherapy.

Cardio-oncology (London, England)·2025

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Molecular Medicine

Background:

  • Gene therapy offers novel disease targets, but clinical translation remains difficult.
  • Cardiovascular gene therapy has largely focused on angiogenesis for ischemia treatment.
  • Early phase 1 trials showed promise, but larger studies have lacked efficacy.

Purpose of the Study:

  • To review technical aspects of cardiovascular gene therapy.
  • To examine recent clinical studies and their outcomes.
  • To explore future directions for cardiovascular gene therapy.

Main Methods:

  • Review of recent literature on cardiovascular gene therapy.
  • Analysis of clinical trial data, focusing on angiogenesis for ischemia.
  • Discussion of technical challenges and safety concerns.

Related Experiment Videos

Main Results:

  • Large-scale efficacy studies for angiogenesis in ischemia have not demonstrated significant clinical improvement.
  • Several gene therapy trials have reported complications, impacting the field's outlook.
  • Despite setbacks, the potential for gene therapy in cardiovascular diseases persists.

Conclusions:

  • Cardiovascular gene therapy faces significant hurdles in clinical application.
  • Future research must address technical limitations and safety concerns.
  • A critical re-evaluation of strategies is needed for effective cardiovascular gene therapy.